• Zum Hauptinhalt springen
  • Zum Footer springen

PSY-PGx

  • About
    • Mission
    • Management & Structure
  • Consortium
  • Research
    • Work Packages
    • Careers
    • Publications
    • Clinical Study
  • Patients
    • Local Websites
    • Clinical Study
  • Media
    • Patient Experiences with Pharmacogenetics
    • Press Releases
    • Patient Inclusion
    • X (formerly Twitter)
  • Internal
  • Events
  • Meet the Team
  • News
  1. PSY-PGx
  2. Research
  3. Work Packages
  4. WP1B: Study Set-up Clinical

WP1B: Study Set-up Clinical

Lead

Fundació Clínic per a la Recerca Biomèdica

Department of Psychiatry & Psychology

Prof. Eduard Vieta

University Maastricht

Department of Psychiatry and Neuropsychology

Prof. Thérèse van Amelsvoort

Participants/Support

  • King’s College London
  • Global Alliance of Mental Illness Advocacy Networks
  • Fundació Clínic per a la Recerca Biomèdica
  • SUNY Upstate Medical University
  • Universitätsklinikum Bonn

Goals

  • Maintain a stringent strategy for clinical data collection
  • Finalize the Clinical Study Document
  • Monitoring and Site visits
  • Quality Control
  • Set-up training for clinical staff and patients

PSY-PGx

A New Intervention for Implementation of Pharmacogenetics in Psychiatry
PSY-PGx Coordinator

Roos van Westrhenen

Psychiatrist & Clinical Pharmacologist (MD, PhD) Parnassia Psychiatric Institute/St. John’s National Academy of Health Sciences, Bangalore, India/King’s College London

Overschiestraat 57
1062 HN Amsterdam, The Netherlands
p-qguéicbpziuiuöcјæsuä

Sitemap

About
Consortium Members
Research
Patients
News
Internal


Funding

This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 945151.

Twitter
Editor login
Imprint | Data-Safety